Humacyte, Inc. (HUMA)
(Delayed Data from NSDQ)
$8.25 USD
-0.37 (-4.29%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $8.33 +0.08 (0.97%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Humacyte, Inc. [HUMA]
Reports for Purchase
Showing records 1 - 3 ( 3 total )
Company: Humacyte, Inc.
Industry: Unclassified
We HAVe a BLA Now; FDA Application Submitted; Reiterate Buy and $6 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Humacyte, Inc.
Industry: Unclassified
We Could HAVe a New Alternative for Treating Vascular Injury Soon; Initiating at Buy With a $6 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Humacyte, Inc.
Industry: Unclassified
|